Cargando…
Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy
PURPOSE OF REVIEW: The aim of the study is to provide an overview on the possibility of treating congenital disorders prenatally with mesenchymal stromal cells (MSCs). RECENT FINDINGS: MSCs have multilineage potential and a low immunogenic profile and are immunomodulatory and more easy to expand in...
Autores principales: | Sagar, Rachel, Walther-Jallow, Lilian, David, Anna L., Götherström, Cecilia, Westgren, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866262/ https://www.ncbi.nlm.nih.gov/pubmed/29600162 http://dx.doi.org/10.1007/s40778-018-0118-8 |
Ejemplares similares
-
Prenatal stem cell therapy for inherited diseases: Past, present, and future treatment strategies
por: Ekblad‐Nordberg, Åsa, et al.
Publicado: (2019) -
Fetal electrocardiography and artificial intelligence for prenatal detection of congenital heart disease
por: de Vries, Ivar R., et al.
Publicado: (2023) -
Prenatal ultrasound and magnetic resonance evaluation and fetal outcome in high‐risk fetal tumors: A retrospective single‐center cohort study over 20 years
por: Ulm, Barbara, et al.
Publicado: (2020) -
Cellular Subsets of Maternal Microchimerism in Umbilical Cord
Blood
por: Kanold, Anna Maria Jonsson, et al.
Publicado: (2018) -
Uptake of fetal aneuploidy screening after the introduction of the non‐invasive prenatal test: A national population‐based register study
por: van der Meij, Karuna R. M., et al.
Publicado: (2021)